HGH Frag 176-191 is a modified peptide fragment derived
from the C-terminal end of human growth hormone (amino
acids 176 to 191). Although it is only a portion of the full
191-amino-acid HGH sequence, it retains powerful fatburning
properties without the broad systemic effects
associated with full-length HGH.

HGH Frag 176-191

$205.00

Excluding Sales Tax |

Quantity

HGH Frag 176-191 is a modified peptide fragment derived from the C-terminal end of human growth hormone (amino acids 176 to 191). Although it is only a portion of the full 191-amino-acid HGH sequence, it retains powerful fatburning properties without the broad systemic effects associated with full-length HGH.
HGH Frag 176-191 is known for its potent fat-burning effects, particularly when combined with a clean diet and regular physical activity. It is most commonly used for reducing abdominal fat, improving muscle definition, and enhancing metabolic flexibility. Because it does not raise insulin or blood glucose, it is often favored in body recomposition programs and weight loss protocols. Additional reported benefits include improved sleep quality, better recovery from exercise, and increased energy levels due to enhanced fat metabolism. It is often used in cycles of 2�3 months, either on its own or in combination with other peptides like AOD 9604 or CJC-1295/Ipamorelin for synergistic effects.
HGH Frag 176-191 mimics the fat-burning effects of natural HGH by binding to the same receptors that regulate lipolysis and fat metabolism�but it avoids the blood sugar and insulin-related effects of full-length HGH. This makes it a highly targeted tool for promoting fat loss without the side effects of systemic growth hormone stimulation. The fragment works by stimulating the breakdown of stored triglycerides in adipose tissue (lipolysis) while simultaneously inhibiting the formation of new fat (lipogenesis). It increases fat oxidation at the mitochondrial level, particularly in visceral and abdominal fat stores, which are typically more resistant to diet and exercise. In animal studies, HGH Frag was shown to reduce body fat by over 50% with no rebound effect and no negative impact on blood glucose levels. Unlike HGH, which affects bone growth, organ size, and carbohydrate metabolism, HGH Frag is non-mitogenic and does not elevate IGF-1 levels�making it safer for adults seeking fat loss without concern for tissue overgrowth or insulin resistance.
HGH Frag 176-191 has shown a high safety profile in both animal and limited human trials. Because it lacks the full growth-promoting effects of HGH, it does not cause organomegaly, glucose intolerance, or unwanted cell proliferation. Side effects are rare and may include mild injection site irritation or temporary fatigue. As with all peptides, quality and source are critical�compounded peptides from 503A/503B pharmacies are preferred to ensure purity and efficacy.

HGH Frag 176-191

Clinical Overview

Benefits

Mechanism of Action

Safety Considerations

Dosing

Monarch Aesthetics